Why Pfizer's 2017 Was Mediocre at Best Post author:Sam Post published:December 12, 2017 Post category:BioPharma Pfizer’s 2017 wasn’t horrible. Just ho-hum. Source: BioSpace You Might Also Like 3 Drugs That Could Make-or-Break AbbVie February 11, 2018 Third Rock Ventures Quietly Launches in Editas Medicine???s HQ March 6, 2017 Why This SoCal Pharma Could Be Your Best Bet on Alzheimer's April 24, 2017
